article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

Lines are blurring between payers and providers More and more, large integrated delivery networks and national payers are battling each other for greater control over patient costs and outcomes. Payers are responding by creating, acquiring or fortifying provider networks and healthcare clinics of their own.

article thumbnail

Female Providers, A Unique Perspective: Part 2

InCrowd

Before the pandemic, I likely lost valuable networking opportunities with providers and representatives from various specialties who would be hosting dinner and information sessions; difficult to rub elbows when you have a daycare or babysitter that is waiting for you, and newborns to feed. in 2007 to 36.3% In 2019, 44.9%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Patient centricity 101: How to create content that REALLY communicates

pharmaphorum

According to the European Commission and NIHR Clinical Research Network, between 2007 and 2011, delays for launching clinical trials rose by 90%. And with approximately one third of the clinical trial timeline spent in patient recruitment, delays in launching clinical trials will increase costs and drain resources.

article thumbnail

The Workforce Now Spans 5 Generations — How Can You Meet Everyone’s Needs?

Salesforce

share-price gain during the 2007-2009 downturn, while the broader stock market declined by 35%, according to an AARP study. share-price gain during the 2007-2009 downturn, while the broader stock market declined by 35%. Inclusive companies (with a diverse workforce across age, gender, race, sexuality, and ability), posted a 14.4%

article thumbnail

Digitalising HPLC methods: the path to interoperability

European Pharmaceutical Review

The Alliance’s network was able to bring together the right mix of expertise. She completed her industry-funded PhD with the University of Portsmouth (UK) in 2007 from the School of Pharmacy. What were the main challenges you encountered? How will this project be expanded in future?

article thumbnail

The Ripple Effect: How Pharmaceutical Advertisements Impact the Industry and Beyond

Pharma Marketing Network

The post The Ripple Effect: How Pharmaceutical Advertisements Impact the Industry and Beyond appeared first on Pharma Marketing Network. As such, it is important for the industry to carefully consider the effects of these advertisements and to take steps to ensure that they are promoting the right messages in the right ways. References: 1.

article thumbnail

Building a business through economic uncertainty: tales from the biotech trenches

Clarivate

The ‘If I Knew Then What I Know Now’ panel has for 15 years been a staple of the annual conference , which brings together biotech companies and investors in London for networking, company presentations and plenary discussions. You have to be patiently impatient,” he said.